tirzepatide black market for Weight Loss & Metabolic Support Found | Weight Loss Medication

Extensive clinical trials have shown that GLP-1 receptor agonists can lead to significant, sustained weight loss in people with obesity or overweight, even if they do not have diabetes

Retatrutide TRIUMPH-1 Results: 28.3% Weight Loss in 2,339 Patients Full Breakdown The pivotal Phase 3 trial confirmed retatrutide's efficacy in the largest obesity study to date

Through virtual consultations, members receive personalized treatment plans that combine FDA-approved GLP-1 medications like Wegovy (semaglutide) with metabolic testing and lifestyle support

However, it's a strong signal that the era of widely available compounded GLP-1s is ending